Recent YSCC Discoveries

For more than 25 years, innovative research on health conditions specifically affecting women, more prevalent in women, or affecting women differently than men has been at the core of Women’s Health Research at Yale.

Mice that received antibodies from Long COVID patients showed symptoms including pain and dizziness, a Yale-led study has found.

The European Medical Journal (EMJ) interviews Mario Strazzabosco, MD, PhD, about developments in liver cancer treatment, the physician-patient relationship, and new discoveries in cholangiocarcinoma (CCA).

Trainee colloquium at YCC

The antinuclear antibody-drug conjugates (ANADCs) were effective against mouse models of breast cancer and colon cancer, and even improved survival in mouse models of glioma, senior author Dr. James Hansen of Yale Cancer Center said. Efforts are now underway to advance this therapy to testing in the clinical trial setting.

Salt Lake City, Utah - July 9-12, 2024 – At the 22nd International Conference on Artificial Intelligence in Medicine, the “Artificial Intelligence for Drug Discovery – Development in Pharmaceuticals, Academia, or Jointly in Collaborations” workshop kicked off at the Hilton Salt Lake City Center with a full audience. The event drew experts from leading institutions and industries to discuss the latest advancements in AI applications for drug discovery. It also showcased one of the largest pharma-academia collaborations in the US, attracting many leaders in the field seeking insights on how to initiate, develop, and grow successful partnerships.

Women’s Health Research at Yale today announced two research awards, one aimed at more effectively treating endometriosis and the second designed to help women who have been incarcerated improve their health outcomes.

A team at Yale, led by Martin Schwartz, PhD, Robert W. Berliner Professor of Medicine (cardiology), has identified a protein that helps your body sense and respond to changes in this shear stress.

The Colton Center for Autoimmunity at Yale is pleased to announce the eleven 2024 Yale projects selected for their promising research in autoimmunity and allergic diseases. In addition to grant funding, Colton Center awardees receive mentorship, access to industry expertise, and feedback on their potential commercialization.